Free tool
Medical devices stocks
We cover 5 companies grouped under the Medical devices theme. The median market value in the group is $4.25B. Across the group, the median move over the past trading day is −1.05%. Price change over the past year runs from +0.4% to +159.6% across the middle 80 percent of the group, with a median of +29.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 349 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0Q15.L | Abbott Laboratories | $200.16B | Mega cap | −9.86% | Oct 14, 2026 |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% | Nov 5, 2026 |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% | Oct 29, 2026 |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% | Nov 5, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.